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all women, 2.92 (P  0.03) in post-menopausal subjects, andAssociation between hypertension and variation in the - and
3.79 (P  0.09) in users of oral contraceptives.-adducin genes in a white population.
Conclusions. The 1797T allele of the -adducin gene is asso-Background. The substitution of tryptophan for glycine at
ciated with increased risk of hypertension in post-menopausalamino acid 460 (Gly460Trp polymorphism) of the -subunit
women and in users of oral contraceptives, particularly in theof the heterodimeric cytoskeleton protein adducin increases
presence of the mutated -adducin Trp allele. We hypothesizerenal sodium reabsorption and may be involved in the patho-
that inhibition of the renin-aldosterone system in men andphysiology of essential hypertension. In the present study, we
absence of such a compensatory mechanism in women mayinvestigated in multivariate analyses whether the risk of hyper-
explain, at least to some extent, the sexual dimorphism of thetension was associated with the C1797T polymorphism of the
blood pressure phenotype in relation to the C1797T -adducin-adducin gene.
polymorphism.Methods. A total of 1848 subjects randomly selected from
a white population were genotyped. Study nurses measured
blood pressure at the participants’ homes.
Results. The frequencies of the-adducin Trp and-adducin Adducin is a ubiquitously expressed membrane-skele-T alleles were 0.23 and 0.11, respectively. In men (N  904),
ton protein, which is composed of either  and  or the -adducin T allele was not associated with hypertension
and  subunits that to a large extent are similar in amino[adjusted relative risk (RR) vs. CC homozygotes 0.94, P 
0.77], but T allele carriers had lower plasma renin activity acid sequence and domain organization [1]. Adducin
(PRA) and 24-hour urinary aldosterone excretion (P  0.04). plays an important role in the determination of cellular
In all women (N  944), -adducin T allele carriers had a morphology and motility and in the regulation of mem-higher risk of hypertension than CC homozygotes (RR 1.81,
brane ion transport [1–3]. Point mutations of the - andCI 1.18–2.77, P  0.007), but similar PRA and 24-hour urinary
-adducin account for up to 50% of the blood pressurealdosterone excretion (P  0.29). In 345 post-menopausal
women and 190 users of oral contraceptives, the RRs of hyper- difference between Milan normotensive and hyperten-
tension were 2.47 (CI 1.34–4.64, P  0.003) and 2.56 (CI sive rat strains [4], probably via the modulation of the
0.83–7.86, P  0.10), respectively. For systolic pressure in Na-K ATPase activity [2, 3]. The Gly460Trp polymor-
women, there was a significant interaction (P  0.02) between
phism of the human -adducin gene is associated with so-the - and -adducin polymorphisms. Only in female carriers
dium sensitivity [5–8]. Hypertensive carriers of the 460Trpof the mutated -adducin Trp allele was the systolic pressure
significantly higher in -adducin T allele carriers compared allele of the -adducin gene, compared with GlyGly ho-
with CC homozygotes (3.8 mm Hg, P  0.02). Furthermore, mozygotes, show an enhanced membrane sodium trans-
in the presence of the mutated -adducin Trp allele, the RRs port rate in erythrocytes [8], higher proximal tubular
associated with the -adducin T allele were 2.35 (P  0.01) in
renal reabsorption of sodium [6, 7], and larger blood pres-
sure changes in response to sodium loading or diuretic
treatment [5]. Several [5, 9, 10], though not all [11, 12],Key words: adducin, hypertension, blood pressure, renin, candidate
gene, blood pressure, point mutation, C1797T polymorphism. studies also found an association between blood pressure
or hypertension and the Gly460Trp polymorphism of theReceived for publication March 26, 2002
-adducin gene [13].and in revised form June 3, 2002
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creases by 30% [14] to 80% [15], whereas the incorpora- Field work
tion of -adducin rises four- [15] to fivefold [14]. Further- Study nurses visited the participants repeatedly in their
more, -adducin deficient mice have higher levels of homes. The same observer measured a subject’s blood
systolic and diastolic blood pressures and pulse pressure pressure five times consecutively at each of two home
[16]. In humans, the genes encoding the - and -adducin visits four to six weeks apart. Conventional sphygmoma-
subunits have been localized to chromosome 4p16 [17] nometry was performed according to the guidelines of
and 2p13 [18], respectively. The human -adducin gene the British Hypertension Society after the subjects had
comprises 17 exons [19]. A common single-nucleotide poly- rested for five minutes in the sitting position. For analy-
morphism (C→T) in the -adducin gene has been identi- sis, we averaged the 10 blood pressure readings. Hyper-
fied at position 1797 in exon 15 (C1797T, starting from tension was diagnosed if the blood pressure was at least
ATG; SNP number, rs4984; URL, http://www.ncbi.nlm. 140 mm Hg systolic or 90 mm Hg diastolic, or when the
nih.gov/SNP/). This change is silent in terms of amino patients were on antihypertensive medication.
acid composition of -adducin. However, alternative We used a standardized and validated [21] question-
splicing including exon 15 causes a frame shift and early naire to collect information on medical history, smoking
termination, yielding the isoform 4, which is a smaller habits, alcohol intake, use of medications and the men-
peptide with an alternative carboxy-terminus as com- strual cycle of women. In the interval between the two
pared with the first described isoform 1 [19]. In the pres- home visits, the participants collected a 24-hour urine
ent study, we investigated whether the risk of hyperten- sample in a wide neck plastic container for the measure-
sion was associated with the C1797T polymorphism of ment of sodium, potassium, aldosterone and creatinine.
the -adducin gene in the presence or absence of the A venous blood sample for the measurement of plasma
mutated -adducin Trp allele. The rationale for explor- renin activity (PRA) was obtained usually within two
ing the interaction between the two adducin polymor- weeks after the urine collection.
phisms was that, if present, it would be compatible with
Determination of genotypesa functional role of adducin rather than with effects of
other polymorphisms in linkage disequlibrium with the Genomic DNA was extracted from peripheral blood.
genes encoding the adducin subunits. Allelic discrimination of the C1797T-adducin polymor-
phism was carried out using the 5 nuclease assay [22] on
an ABI Prism 7700 apparatus (Perkin Elmer, Foster City,METHODS
CA, USA). The forward and reverse primers and the 1797C
Study population and 1797T probes employed in the TaqMan assay were
The protocol of the Flemish Study on Environment, 5-AGGAACGAGAGCCAGGCTCT-3, 5-TTCATCA
Genes and Health Outcomes (FLEMENGHO) was ap- AAACACACACCTACCAAT-3, 5-VIC-TTCTTCAG
proved by the Ethics Committee of the University of CGTTGCCCTCCACAT-TAMRA-3 and 5-FAM-TTC
Leuven. All subjects gave informed consent. From Au- TTCAGTGTTGCCCTCCACATCTG-TAMRA-3, re-
gust 1985 until November 1990, a random sample of the spectively. Per 25	L, the polymerase chain reaction (PCR)
households living in a geographically defined area of fluid contained 50 ng DNA, 200 nmol primers, 50 nmol
Northern Belgium [20] was investigated with the goal to FAM-probe and 100 nmol VIC-probe. The amplification
recruit an equal number of participants in each of six conditions were 50
C for two minutes and 95
C for ten
subgroups by sex and age (20 to 39, 40 to 59, and 60 minutes, followed by 40 cycles at 95
 for 15 seconds and
years). All household members with a minimum age of 62
C for one minute. For determination of the Gly460Trp
20 years were invited to take part, until the quota of -adducin gene polymorphism, PCR and subsequent ge-
their sex-age group had been fulfilled. To further study notyping were performed as described previously [23].
the role of genetic factors, from June 1996 until Decem-
Statistical analysisber 2000, nuclear families including children who were
at least 10 years old were recruited, using the former We used the Statistical Analysis System, version 8.1
participants (1985 to 1990) as index persons. (SAS Institute, Cary, NC, USA), for database manage-
The study population included 2272 persons. The par- ment and statistical analysis. Continuous measurements
ticipation rate among the subjects contacted was 66.1%. with a skewed distribution were normalized by logarith-
The blood pressure of 21 participants had not been mea- mic transformation and represented by the geometric
sured. Blood for DNA extraction could not be obtained mean with 95% confidence interval. The Fisher exact test
from 403 former participants, because they did not con- was used to compare genotype and allele frequencies
sent (N  161) or because they had died (N 180), were between normotensive subjects and hypertensive patients.
terminally ill (N 28), or had moved out of the area (N Analysis of covariance (ANCOVA) was performed to test
genetic associations with continuous phenotypes by com-34). Thus, 1848 subjects were included in this analysis.
Wang et al: Hypertension and - and b-adducin2154
Table 1. Characteristics of the participants
Characteristic Mena Womena P
Number % 904 (48.9) 944 (51.1)
Age years 42.216.3 42.716.2 0.54
Body mass index kg/m2 25.43.9 25.05.1 0.08
Systolic blood pressure mm Hg 125.514.7 120.816.7 0.001
Diastolic blood pressure mm Hg 77.210.5 74.110.2 0.001
Pulse rate beat/min 67.49.2 70.89.6 0.001
Prevalence of hypertension 217 (24.0) 206 (21.8) 0.26
Taking antihypertensive drugs 91 (10.1) 121 (12.8) 0.06
Plasma renin activity ng/L/sec 0.49 (0.46–0.52) 0.47 (0.44–0.50) 0.23
Urinary volume L/day 1.480.61 1.560.70 0.02
Creatinine excretion mmol/day 13.73.6 9.22.4 0.001
Sodium excretion mmol/day 20269 16558 0.001
Potassium excretion mmol/day 7730 6324 0.001
Urinary Na/K ratio 2.841.07 2.801.10 0.42
Aldosterone excretion nmol/day 25.6 (24.3–26.9) 27.1 (25.5–28.8) 0.15
Values are arithmetic means  SD, geometric means (95% confidence interval), or number of subjects (%).
a Plasma renin activity was measured in 711 men and 739 women. Urinary volume, creatinine and electrolytes were available in 889 men and 933 women, respectively.
Urinary aldosterone was measured in 574 men and 598 women.
Table 2. Genotype and allele frequencies
Genes Genotypes P a Alleles P a
-Adducin GlyGly GlyTrp TrpTrp Gly Trp
Men (N  904)
Normotensive 420 (61.1) 230 (33.5) 37 (5.4) 1070 (77.9) 304 (22.1)
Hypertensive 137 (63.1) 72 (33.2) 8 (3.7) 0.63 346 (79.7) 88 (20.3) 0.46
Women (N  944)
Normotensive 423 (57.3) 268 (36.3) 47 (6.4) 1114 (75.5) 362 (24.5)
Hypertensive 117 (56.8) 79 (38.4) 10 (4.8) 0.71 313 (76.0) 99 (24.0) 0.90
-Adducin CC CT TT C T
Men (N  904)
Normotensive 549 (79.9) 131 (19.1) 7 (1.0) 1229 (89.4) 145 (10.6)
Hypertensive 174 (80.2) 42 (19.3) 1 (0.5) 0.88 390 (89.9) 44 (10.1) 0.86
Women (N  944)
Normotensive 593 (80.4) 141 (19.1) 4 (0.5) 1327 (89.9) 149 (10.1)
Hypertensive 152 (73.8) 51 (24.8) 3 (1.4) 0.06 355 (86.2) 57 (13.8) 0.04
a Fisher’s exact test was used to compare hypertensive patients with normotensive subjects
paring wild-type homozygotes with carriers of mutated antihypertensive drug treatment (Table 1). The subjects
ranged in age from 10 to 84 years. Among men, 31.1%alleles, while controlling for covariables and confound-
ers. Multiple logistic regression was used to estimate the (N  281) were current smokers, and 36.1% (N  326)
reported intake of alcohol. In women these proportionsadjusted relative risk of hypertension associated with the
mutated alleles. To test genetic interactions, we defined were 27.7% (N 262) and 13.5% (N 127), respectively.
Three hundred and forty-five women (36.6%) reporteddummy variables coded 0 or 1 depending on the absence
or presence of the mutated alleles. Finally, our analyses natural or surgical menopause, 190 (20.1%) used oral con-
were repeated using generalized estimating equations to traceptives and 32 (3.4%) took hormonal replacement
allow for the non-independence of the phenotypes within therapy.
families [24]. In the PROC GENMOD procedure of the
Single-gene analysesSAS package, the intra-familial correlation matrices were
defined based on our own data with adjustments applied The frequencies of the-adducin (P 0.65) and-addu-
for covariables. cin (P  0.14) genotypes did not deviate from Hardy-
Weinberg equilibrium. In unadjusted single-gene analy-
ses, the prevalence of hypertension was not associated
RESULTS
with the genotype or allele frequencies of the -adducin
Characteristics of the subjects gene, whereas the frequencies of the -adducin CT and
TT genotypes and the T allele tended to be higher in hy-The 1848 participants included 904 men (48.9%) and
423 hypertensive patients (22.9%), of whom 212 were on pertensive compared with normotensive women (Table 2).
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Table 3. Single-gene associations with systolic and diastolic pressures, urinary Na/K ratio, plasma renin activity and aldosterone excretion
-Adducin -Adducin -Adducin -Adducin
GlyGly GlyTrpTrpTrp CC CTTT
Variable N Statistic N Statistic P a N Statistic N Statistic P a
Men
Systolic pressure mm Hg 557 126.10.6 347 124.50.7 0.07 723 125.60.5 181 125.21.0 0.69
Diastolic pressure mm Hg 557 77.40.4 347 76.70.5 0.28 723 77.00.3 181 77.90.7 0.22
Urinary Na/K ratio 504 2.810.05 306 2.870.06 0.46 651 2.840.04 159 2.810.08 0.68
Plasma renin activity ng/L/sec 393 0.50 (0.47–0.54) 250 0.47 (0.43–0.52) 0.33 513 0.51 (0.48–0.54) 130 0.44 (0.38–0.50) 0.04
Aldosterone excretion nmol/day 402 25.5 (23.7–27.3) 208 25.2 (23.1–27.4) 0.83 404 26.2 (24.7–27.8) 106 22.3 (19.9–25.1) 0.02
Urinary aldosterone/K ratio 402 0.35 (0.32–0.37) 208 0.35 (0.32–0.38) 0.94 404 0.36 (0.33–0.38) 106 0.31 (0.27–0.35) 0.04
Women
Systolic pressure mm Hg 540 121.00.6 404 120.50.6 0.58 745 120.60.5 199 121.40.9 0.46
Diastolic pressure mm Hg 540 74.30.4 404 73.90.4 0.41 745 73.80.3 199 75.10.6 0.08
Urinary Na/K ratio 466 2.770.05 355 2.830.06 0.37 655 2.750.04 166 2.980.08 0.01
Plasma renin activity ng/L/sec 379 0.46 (0.42–0.50) 264 0.45 (0.41–0.49) 0.70 501 0.45 (0.42–0.49) 142 0.45 (0.39–0.51) 0.93
Aldosterone excretion nmol/day 295 27.5 (25.3–29.8) 206 26.8 (24.3–29.6) 0.72 388 27.7 (25.7–29.7) 113 25.7 (22.4–29.4) 0.34
Urinary aldosterone/K ratio 295 0.45 (0.41–0.49) 206 0.46 (0.42–0.51) 0.65 388 0.45 (0.42–0.49) 113 0.45 (0.40–0.52) 0.97
Values are arithmetic means  SE or geometric means (95% CI). Systolic and diastolic blood pressures were adjusted for age, age2, body mass index, smoking,
alcohol intake, and use of antihypertensive drugs or oral contraceptives. Plasma renin activity (PRA) and the urinary measurements were adjusted for age, body
mass index and, in women, for the use of oral contraceptives. Urinary aldosterone excretion and PRA were also adjusted for 24-hour urinary sodium excretion, and
for PRA, also for the time of day at which the blood had been sampled.
a P value for comparisons between GlyGly or CC homozygotes and Trp or T allele carriers, respectively
With adjustment for age, age2, body-mass index, smok-
ing, alcohol intake and use of antihypertensive drugs
or oral contraceptives, the single-gene associations with
blood pressure did not reach statistical significance (Ta-
ble 3). However, with similar adjustments applied, we
found for hypertension a significant interaction (P 
0.03) between the -adducin C1797T polymorphism and
gender (Fig. 1). In men, the risk of hypertension was
similar across the -adducin C1797T genotypes (P 
0.77), whereas in women it was significantly higher in T
allele carriers than in CC homozygotes [relative risk
(RR) 1.81, 95% confidence intervals (CI) 1.18-2.77, P 
0.007]. The latter association was driven by the results
in 345 post-menopausal women (RR 2.47, 95% CI
1.34–4.64, P 0.003) and 190 users of oral contraceptives
(RR 2.56, 95% CI 0.83–7.86, P  0.10), whereas it was
Fig. 1. Risk of hypertension in -adducin T allele carriers versus CC
not observed in the pre-menopausal subjects who did homozygotes in men and women, in users (OC) and non-users (OC)
of oral contraceptives and in post-menopausal women. Squares repre-not take oral contraceptives (RR 0.85, 95% CI 0.35–2.06,
sent odds ratios adjusted for age, age2, body-mass index, smoking, alco-P  0.72). For -adducin, the sex-by-genotype interac-
hol intake and, in all women, for the use of oral contraceptives. The
tion was not significant (P  0.14). If the non-indepen- size of the squares is proportional to the number of cases given alongside
the symbols. Vertical lines denote 95% confidence intervals. Numberdence of phenotypes within families also was accounted
of subjects (N) and significance levels for odds ratios (P) and for thefor, the above results remained unaltered. sex-by-genotype interaction (P-int) are given.
In further analyses of PRA and the urinary measure-
ments, we excluded participants using antihypertensive
medications because of the divergent effects of different lower in -adducin T allele carriers than in CC homozy-
drug classes on the renin-aldosterone system. Men and gotes (Table 3). In women, the urinary Na/K ratio
women were analyzed separately. We allowed for age, was higher in T allele carriers than in CC homozygotes
body mass index (BMI), and in women also for the use (P  0.01) and the strength of the latter association
of oral contraceptives. In addition, urinary aldosterone tended to increase with use of oral contraceptives (Table
excretion and PRA were also adjusted for 24-hour urinary 4 and Fig. 2).
sodium excretion, and for PRA, also for the time of day
Interaction between the - and -adducin genesat which the blood had been sampled. In men (P 0.04),
but not in women (P  0.34), the adjusted values of PRA With similar adjustments as before, further analyses
in women showed a significant interaction (P  0.02)and urinary aldosterone excretion were significantly
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Table 4. Single-gene associations between biochemical measurements and -adducin polymorphism in women
CC CTTT
Variable N Statistic N Statistic P a
Non-users of oral contraceptives
Urinary Na/K ratio 310 2.750.07 79 3.000.13 0.09
Plasma renin activity ng/L/sec 236 0.48 (0.44–0.54) 67 0.47 (0.38–0.56) 0.72
Aldosterone excretion nmol/day 185 28.8 (25.9–32.1) 54 26.1 (21.3–31.8) 0.38
Urinary aldosterone/K ratio 185 0.48 (0.43–0.53) 54 0.48 (0.39–0.58) 0.97
Users of oral contraceptives
Urinary Na/K ratio 145 2.870.09 37 3.390.18 0.01
Plasma renin activity ng/L/sec 103 0.54 (0.47–0.62) 29 0.63 (0.49–0.82)b 0.28
Aldosterone excretion nmol/day 85 37.1 (31.6–43.6)b 28 33.7 (25.5–44.7) 0.56
Urinary aldosterone/K ratio 85 0.61 (0.51–0.72)b 28 0.62 (0.47–0.83)b 0.89
Post-menopausal women
Urinary Na/K ratio 200 2.650.07 50 2.680.14 0.85
Plasma renin activity ng/L/sec 162 0.37 (0.32–0.42) 46 0.35 (0.27–0.45) 0.76
Aldosterone excretion nmol/day 118 20.6 (18.5–23.0)b 31 20.6 (16.7–25.5) 0.99
Urinary aldosterone/K ratio 118 0.33 (0.30–0.37)b 31 0.33 (0.27–0.41)b 0.95
Values are arithmetic means  SE or geometric means (95% CI), adjusted for age and body mass index. Urinary aldosterone excretion and plasma renin activity
(PRA) were also adjusted for 24-hour urinary sodium excretion and, for PRA, also for the time of day at which the blood had been sampled.
a P value for comparisons between CC homozygotes and T allele carriers
b P  0.05 vs. non-users of oral contraceptives
post-menopausal subjects and 3.79 (95% CI 0.82–17.52,
P  0.09) in users of oral contraceptives, respectively.
Finally, in the presence of the mutated -adducin Trp
allele, PRA was lower in male -adducin T allele carriers
than their CC homozygous counterparts (geometric
means 0.38 vs. 0.50, P  0.02), whereas in female Trp
allele carriers the opposite was observed for urinary Na/
K ratio (CTTT vs. CC 3.12 vs. 2.77, P  0.02).
DISCUSSION
In our white population, the mutated -adducin T al-
lele was associated with an approximately twofold in-
crease in the risk of hypertension in post-menopausal
women and in users of oral contraceptives. In contrast,
the T allele of the -adducin gene was not associated
with hypertension in pre-menopausal women not using
oral contraceptives and in men. In the presence of the
mutated -adducin Trp allele, the association betweenFig. 2. Urinary Na/K ratio by -adducin genotype in users (OC)
and non-users (OC) of oral contraceptives and in post-menopausal systolic pressure and the -adducin T allele in all women
women. Circles (CC genotype) and dots (T allele carriers) represent was significantly enhanced, while similar trends were ob-
means adjusted for age and body-mass index. Vertical lines denote SEs.
served for the risk of hypertension in all women, users ofNumber of subjects (N) and significance levels (P) for the differences
between T allele carriers and CC homozygotes are given. oral contraceptives and post-menopausal subjects. The
prevalence of hypertension in post-menopausal women
was 43%. The positive predictive value and attributable
risk associated with the -adducin T allele therefore maybetween the - and -adducin polymorphisms in relation
be estimated to be 80.9% and 24.7%, respectively [25].to systolic blood pressure. Only in the presence of the
In post-menopausal -adducin Trp allele carriers, thesemutated -adducin Trp allele was systolic pressure sig-
proportions would be 91.7% and 13.5%, respectively [25].nificantly higher in -adducin T allele carriers than CC
Several lines of evidence support a possible associationhomozygotes (123.5 vs. 119.7 mm Hg, P 0.02). Further-
between hypertension and the -adducin mutation. First,more, in the presence of the mutated -adducin Trp
adducin modulates several mechanisms of membrane so-allele, the relative risks of hypertension associated with
dium transport, which may play an important role in the-adducin T allele were 2.35 (95% CI 1.23–4.52, P 
0.01) in all women, 2.92 (95% CI 1.11–7.67, P  0.03) in pathophysiology of hypertension, such as Na pump ac-
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tivity, Na-K-CI cotransport, Li-Na countertransport giotensinogen [30, 31]. Higher levels of plasma angioten-
and passive Na permeability [2, 3, 8]. Second, -adducin sinogen may produce a small increase of PRA and angio-
deficiency in mice leads to higher levels of systolic and tensin II [31]. A slight rise in the intrarenal angiotensin II
diastolic blood pressures and pulse pressure [16]. Third, level may be sufficient for a reduction in renal blood flow,
point mutations of - and -adducin account for 50% of which in turn may lead to increases in exchangeable so-
the blood pressure difference between Milan normoten- dium and blood pressure [31]. Furthermore, exogenously
sive and hypertensive rat strains [4]. The function of administered progestogens may induce natriuresis and
the C1797T -adducin polymorphism is still unknown. lead to a compensatory activation of the renin-angioten-
However, in the present study the mutated -adducin Trp sin aldosterone system [29]. In keeping with this working
allele apparently potentiated the risk of hypertension hypothesis, we found that women using oral contracep-
associated with the -adducin 1797T allele in women. In tives compared with non-users had a significantly higher
humans, the mutated -adducin 460Trp allele is associ- PRA and urinary aldosterone excretion (Table 4). They
ated with enhanced sodium reabsorption at the proximal also had an increased urinary Na/K ratio, which may
renal tubules [6, 7]. Therefore, we hypothesize that the be the expression of the antagonism of aldosterone at the
-adducin mutation also increases the risk of hyperten- receptor level by exogenous progestogens. Competitive
sion via increased sodium reabsorption and chronic vol- antagonism of the renal tubular aldosterone receptors
ume expansion. may entail a further stimulation of the adrenal aldoste-
The renin-angiotensin-aldosterone system may play a rone secretion through potassium retention.
role in the sexual dimorphism of blood pressure [26]. This The significant association between hypertension and
concept may explain why the mutated -adducin T allele -adducin in post-menopausal women may be explained
was associated with hypertension in women but not in by the disappearance of the protective effects of the
men. Indeed, inhibition of PRA and the adrenal aldoste- endogenous female sex hormones [27, 32]. Post-meno-
rone secretion, as exemplified by the diminished urinary pausal subjects in the present study showed no difference
aldosterone excretion, may represent a counter-regula- in the urinary Na/K ratio across the -adducin geno-
tory mechanism in response to the chronic volume ex- types (Fig. 2). In the absence of endogenous progester-
pansion induced by the mutated adducin. Thus, in men one, natriuresis is not stimulated and the aldosterone-
inhibition of the renin-aldosterone system probably un- induced potassium excretion is not inhibited [33]. In the
derlies the lack of association between hypertension and absence of hormonal replacement therapy, the elasticity
the mutated -adducin T allele. No difference was ob- of the large arteries of post-menopausal women declines
served in the PRA or urinary aldosterone excretion of and systolic blood pressure may consequently rise [32,
women in relation to the -adducin genotypes.
34, 35]. Without the vasodilatory and the natriuretic pro-
In women, the association between hypertension and
tection of female sex hormones, post-menopausal womenthe -adducin polymorphism was dependent on meno-
have a diminished potential to compensate for geneticpausal status and the intake of oral contraceptives in pre-
mechanisms that might increase their blood pressuremenopausal subjects. Young women not using oral con-
through chronic volume expansion, stiffening of the largetraceptives may be protected against hypertension by
arteries or peripheral arterial vasoconstriction [32]. Fur-their endogenous sex hormones [26]. The acute and long-
thermore, the activity of the renin-angiotensin-aldoste-term vasodilatory effects of estradiol are well-documented
rone axis decreases with aging [36] and hence the possi-[27, 28], and this sex steroid may counteract the develop-
bility to compensate for increased sodium retention viament of hypertension. Endogenous progesterone has na-
inhibiton of this system may be attenuated. In the ab-triuretic and blood pressure lowering effects, mainly due
sence of regulatory and counter-regulatory mechanisms,to its competition with mineralocorticoids at the type 1
sodium fluid balance mainly depends on renal sodiumcorticosteroid receptor [29]. The higher urinary Na/K
handling [37]. The membrane skeleton protein adducinratio observed in pre-menopausal T allele carriers com-
is an important determinant of proximal tubular sodiumpared with their CC homozygous counterparts in our
reabsorption [6, 7]. Based on previous findings in experi-study may reflect competitive antagonism of aldosterone
mental animals [4] and hypertensive patients [5], weat distal renal tubule, which may compensate for the
speculate that in post-menopausal women, chronic so-enhanced proximal tubular sodium reabsorption associ-
dium retention and expansion of the circulating volumeated with mutated adducin.
associated with the mutated adducin may explain theThe favorable vascular and natriuretic effects of the
increase in blood pressure.endogenous female sex hormones may be overruled by
A limitation of our study was that DNA had not beenthe use of oral contraceptives, due to the activation of
obtained from 17.7% of our previously recruited cohortrenin-angiotensin-aldosterone system [29]. Exogenous
including 180 subjects (44.7%) who died before our ge-estrogens, given orally and particularly in higher doses,
stimulate the synthesis of hepatic proteins including an- netic study was initiated. However, selective survival is
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